Search

Your search keyword '"Castañeda, S."' showing total 1,054 results

Search Constraints

Start Over You searched for: Author "Castañeda, S." Remove constraint Author: "Castañeda, S."
1,054 results on '"Castañeda, S."'

Search Results

1. Derecho natural y de gentes en Vitoria y Grocio: ¿linajes diferentes?

8. OP0014 TRANSCRIPTS EXPRESSED IN TEMPORAL ARTERY BIOPSIES ASSOCIATED WITH RESPONSE TO THERAPY IN PATIENTS WITH GIANT CELL ARTERITIS

9. POS1007 THE INVOLVEMENT OF THE C5 AND C5AR1 GENES IN THE PATHOGENESIS OF IgAV

10. AB1240 NLRP3 AND CASP1 GENES AS DISCRIMINATORY MARKERS BETWEEN IGA VASCULITIS AND IGA NEPHROPATHY?

11. AB0694 BARICITINIB IN RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 60 PATIENTS

12. POS0111 BENEFICIAL EFFECT OF TEMPORARY METHOTREXATE WITHDRAWAL ON B AND T CELL RESPONSES UPON SARS-CoV-2 VACCINATION IN PATIENTS WITH RHEUMATOID ARTHRITIS OR PSORIATIC ARTHRITIS

13. AB1318 EFFECTIVENESS OF TOCILIZUMAB IN AORTITIS AND ANEURYSMS ASSOCIATED WITH GIANT CELL ARTERITIS. MULTICENTER OPEN-LABEL STUDY

14. POS0077 EFFECTIVENESS OF JANUS KINASE INHIBITORS IN RELAPSING GIANT CELL ARTERITIS IN REAL-WORLD CLINICAL PRACTICE AND REVIEW OF THE LITERATURE

15. POS0256 THE FIRST METHYLOME PROFILING STUDY OF B-CELLS IN IGA VASCULITIS REVEALED POTENTIAL BIOMARKERS OF DISEASE SUSCEPTIBILITY

16. AB1000 ANIFROLUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS. SPANISH NATIONAL REGISTRY IN A REAL-WORLD SETTING

17. POS1375 THE WINDOW OF OPPORTUNITY: A CONCEPT ALSO APPLICABLE TO UNDIFFERENTIATED ARTHRITIS

18. AB1278 THE ROLE OF NLRP1 POLYMORPHISMS IN THE PATHOGENESIS OF GIANT CELL ARTERITIS

19. POS0689 WINDOW OF OPPORTUNITY IN THE TREATMENT OF RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE WITH ABATACEPT. NATIONAL MULTICENTER STUDY OF 526 PATIENTS

20. OP0025 GENOME-WIDE DNA METHYLATION STUDY REVEALS SPECIFIC SIGNATURES IN THE AFFECTED ARTERIAL TISSUE OF GIANT CELL ARTERITIS PATIENTS

21. POS1424 TOCILIZUMAB IN EXTRACRANIAL LARGE-VESSEL GIANT CELL ARTERITIS AND TAKAYASU ARTERITIS: COMPARATIVE MULTICENTER STUDY

22. POS0925 VISUAL MANIFESTATIONS IN GIANT CELL ARTERITIS: IDENTIFICATION OF RISK FACTORS FROM THE ARTESER REGISTRY

24. A Review of the Dermatological Complications of Giant Cell Arteritis

25. Fisiopatología de la osteoporosis en las enfermedades articulares inflamatorias crónicas

27. The enigma of rare Quaternary oolites in the Indian and Pacific Oceans: A result of global oceanographic physicochemical conditions or a sampling bias?

30. AB0173 MUCOSAL IMMUNE DEFENCE POLYMORPHISMS: RELEVANT PLAYERS IN IGA VASCULITIS?

32. POS0035 INFLUENCE OF INTERSTITIAL LUNG DISEASE DURATION ON THE TREATMENT OF RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 392 PATIENTS WITH ABATACEPT

33. POS0835 EFFECTIVENESS AND SAFETY OF JAK INHIBITORS IN RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 57 PATIENTS

34. OP0102 IDENTIFICATION OF NEW RISK LOCI AND PATHWAYS INVOLVED IN GCA PATHOGENESIS BY A GENOME-WIDE STUDY

35. AB0416 SUBCUTANEUS VS INTRAVENOUS ABATACEPT IN RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 392 PATIENTS

36. AB0709 EFFECTIVENESS OF JANUS KINASE INHIBITORS IN GIANT CELL ARTERITIS IN CLINICAL PRACTICE. REAL-WORLD CLINICAL PRACTICE STUDY AND LITERATURE REVIEW

37. OP0126 LONG-TERM FOLLOW UP OF ABATACEPT IN USUAL INTERSTITIAL PNEUMONIA ASSOCIATED TO RHEUMATOID ARTHRITIS. NATIONAL MULTICENTER STUDY OF 172 PATIENTS

38. POS0363 SEX DIFFERENCES IN CARDIOVASCULAR AND DISEASE-RELATED FEATURES IN AXIAL SPONDYLOARTHRITIS. A MULTICENTERSTUDYOF 912 PATIENTS

39. POS0808 MICA/B-DEPENDENT ACTIVATION OF CYTOTOXIC NATURAL KILLER CELLS BY INFLAMMATORY CDC2 CONTRIBUTE TO PRIMARY SJÖGREN´S SYNDROME PATHOLOGY

40. AB0707 PREDICTIVE FACTORS OF RELAPSE IN GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB

41. POS1112 COMBINED BIOLOGICAL OR TARGETED THERAPY IN SPONDYLOARTHRITIS: EXPERIENCE FROM A MULTICENTER CASE SERIES IN SPAIN

42. POS1030 DNA-METHYLATION PROFILING IN THE BLOOD OF PATIENTS WITH RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE

43. POS0864 EFFECTIVENESS OF ANTIFIBROTICS IN RHEUMATOID ARTHRITIS-INTERSTITIAL LUNG DISEASE. NATIONAL MULTICENTER STUDY OF 50 PATIENTS IN CLINICAL PRACTICE

44. AB0166 IGAV AND IGAN: A SINGLE ENTITY REGARDING CD40, BLK AND BANK1 POLYMORPHISMS

46. POS1142 SPANISH NATIONAL REGISTRY OF BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

47. Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway

49. Osteoclastos: mucho más que células remodeladoras del hueso

Catalog

Books, media, physical & digital resources